Quetiapine 00310-0520
Product NDC
00310-0520- Manufacturer
- Astrazeneca Pharmaceuticals Lp
- Dosage Form
- Tablet, Extended Release
- Product Type
- Drug For Further Processing
- Marketing Start
- April 22, 2022
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Quetiapine Fumarate | 200 mg/1 |
Packaging Options(1)
16667 TABLET, EXTENDED RELEASE in 1 BAG (0310-0520-10)